Business
Covid: Oxford/AstraZeneca vaccine delivery to EU to be cut by 60% – The Guardian
Official says supply will be halved in first quarter of 2021 due to production problems
AstraZeneca is to cut deliveries of its Covid-19 vaccine to the EU by 60% in the first quarter of the year due to production problems, a senior official has told Reuters.
The jab it developed with the University of Oxford is already in widespread use in the UK, but the European Union has not yet approved it. It is expected to make a decision by 29 January.
AstraZeneca said in a statement to Agence-France Presse that if EU approval is granted, the initial volumes will be lower than anticipated.
The…
-
Business17 hours ago3 of the best ASX shares to buy with $5,000
-
Noosa News16 hours agoElderly pair killed in rural highway intersection crash with caravan
-
Business13 hours agoUp 29% since April, why is this ASX 200 coal stock tumbling today?
-
Business9 hours agoWhy 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today